Delivering Value To Those We Serve

News Releases

  • November 3, 1999 at 12:00 AM EST
    FOSTER CITY, Calif. – November 3, 1999 – DepoMed, Inc. (AMEX: DMI) announced today a net loss of $1,459,000, or $0.23 per share, compared to a net loss of $645,000, or $0.10 per share, for the third quarter of 1998. Cash and investment balances at September 30, 1999 were $6,003,000.
  • November 1, 1999 at 12:00 AM EST
    FOSTER CITY, Calif. - November 1, 1999 - DepoMed, Inc. (AMEX: DMI) today announced that U.S. Patent No. 5,972,389, covering the controlled-release of “sparingly soluble drugs and insoluble matter from a gastric retentive system,” has been issued by the United States Patent and Trademark Office.
  • September 21, 1999 at 12:00 AM EDT
    FOSTER CITY, Calif. – September 21, 1999—DepoMed, Inc. (AMEX: DMI) today announced the launch of its new web site, www.depomedinc.com. The site was developed to enhance communication and sharing of information with shareholders and collaborators. The web site allows visitors easy access to a
  • August 17, 1999 at 12:00 AM EDT
    FOSTER CITY, Calif. - August 17, 1999 - DepoMed, Inc. (AMEX: DMI) announced today a net loss of $1,163,000, or $0.18 per share, compared to a net loss of $586,000, or $0.09 per share, for the second quarter of 1998. Cash and investment balances at June 30, 1999 were $7,078,000.
  • April 28, 1999 at 12:00 AM EDT
    FOSTER CITY, CALIF., - April 28, 1999 ..... DepoMed, Inc. (AMEX: DMI) announced today revenues of $115,000 for the quarter ended March 31, 1999 compared to $110,000 for the quarter ended March 31, 1998. The Company reported a net loss of $1,008,000, or $0.16 per share, for the quarter ended March
  • April 21, 1999 at 12:00 AM EDT
    FOSTER CITY, CA , April 21, 1999 - DepoMed, Inc. (AMEX: DMI) today announced that Bristol-Myers Squibb Company (NYSE: BMY) will not exercise a license and development option to use DepoMed's Gastric Retention (GR) System for an undisclosed pharmaceutical product.
  • March 1, 1999 at 12:00 AM EST
    FOSTER CITY, CA - March 1, 1999 - DepoMed, Inc. (AMEX: DMI) reported revenues of $763,000 for the year ended December 31, 1998, compared to $605,000 for the year ended December 31, 1997. The Company recorded a net loss of $2,780,000, or $0.44 per share, for the year ended December 31, 1998 compared
  • February 11, 1999 at 12:00 AM EST
    FOSTER CITY, Calif., - February 11, 1999 - Executives at DepoMed, Inc. (AMEX: DMI) will present at the Cruttenden Roth Eleventh Annual Growth Stock Conference today. DepoMed, Inc. is engaged in the development of controlled-release drug delivery technologies designed to improve the efficacy and
  • December 7, 1998 at 12:00 AM EST
    FOSTER CITY, CALIF., – December 7, 1998 ..... DepoMed, Inc. (AMEX: DMI) today announced the appointment of Bret Berner, Ph.D., as Vice President, Product Development. Dr. Berner was most recently Vice President, Development at Cygnus Therapeutic Systems.
  • November 6, 1998 at 12:00 AM EST
    FOSTER CITY, CALIF., - November 6, 1998 .. DepoMed, Inc. (Nasdaq: DPMD) announced that its common stock and warrants (Nasdaq: DPMDW) have been approved for listing on the American Stock Exchange under the symbols "DMI" and "DMIW," respectively. The Company expects trading to begin on Monday,